LES Research Triangle Park Chapter presents:
Keep Calm and CRISPR On - The State of the Science, Business, & Ethics of CRISPR
Presentation and Lunch
Thursday, May 30, 2019: 11:30 am - 1:30pm Eastern
Research in the early 2000’s began to shed light on the capabilities of CRISPR to function as a gene editing tool that can very efficiently delete, repair, or replace genes. CRISPR was then rapidly recognized for its potential applications in research, therapeutics, agriculture, and industrial biotechnology. Enthusiasm around CRISPR has been met with concerns regarding intellectual property battles, potential off-target mutations, and ethical implications surrounding its use in humans. Meanwhile, breakthroughs in CRISPR technology continue to arise from both the commercial and academic sectors which could enhance target specificity and fine-tune CRISPR for various applications. The number of CRISPR-related startup companies is exploding and the first CRISPR-related clinical trial in the U.S. began earlier this year.
This presentation will provide an overview of the state of CRISPR and its applications, including the commercial landscape for CRISPR technologies, hurdles for advancement, and ethical, regulatory, and policy considerations for application of these technologies.
Dr. Rodolphe Barrangou
Dr. Rodolphe Barrangou is a world renowned expert and pioneer in the discovery and application of CRISPR technology. Dr. Barrangou’s foundational work began as an employee at Danisco, a food ingredients company which is now a part of DuPont, where he was working to develop better bacterial starter cultures for cheese and yogurt. In 2007, he and his colleagues published their findings in Science that demonstrated CRISPR is an adaptive immune system used by bacteria to protect against bacteriophages. Dr. Barrangou joined NC State as faculty in 2013, where he is a Todd R. Klaenhammer Distinguished Scholar in Probiotics Research and Professor of food, bioprocessing and nutrition sciences.
Dr. Barrangou is a co-founder of both Intellia Therapeutics and Locus Biosciences, which recently announced a sizable deal with Janssen Pharmaceuticals to develop microbiome-targeted therapies. He also serves as the inaugural editor-in-chief of The CRISPR Journal, a peer-reviewed publication which launched in January 2018. Dr. Barrangou is highly decorated for his innovative research in CRISPR systems, for which he has authored or co-authored more than 150 peer-reviewed publications and is an inventor on more than 50 issued and pending patents. He was elected into the National Academy of Sciences (NAS) in 2018 and the National Academy of Engineering in 2019. In addition to many other honors, he has been awarded the 2018 NAS Prize in Food and Agriculture Sciences, the 2017 NAS Award in Molecular Biology, the 2016 Warren Alpert Foundation Prize and the 2016 Canada Gairdner International Prize.
Dr. Barrangou earned his bachelor’s degree in biological sciences from the Rene Descartes University in Paris, France; a master’s degree in biological engineering from the University of Technology in Compiegne, France; a master’s degree in food science and a Ph.D. in genomics from NC State; and a MBA from the University of Wisconsin-Madison.
Before May 23:
LES Member: $30
After May 23:
LES Member: $35
The RTP Chapter uses online registration for members and non-members and accepts payment by credit card. Members should login to the registration page with their LES online account.
A $5.00 cancellation fee is applied to all refunds. Cancellations are non-refundable after May 23. Substitutions are accepted. Contact LES at (703) 234-4058 for assistance.
Requests for ADA accommodations and special dietary needs should be submitted to the event contact listed at the top of the page.
By registering for this event, you permit LES and its chapters to use photographs of you with or without your name and for any lawful purpose, including for example such purposes as publicity, illustration, advertising, and web content.